Traduction de «for the recognition of pharmacists » (Néerlandais → Français) :

Advisory commission which is consulted e.g. in cases of non-availability of medicines Commission for the approval of institutions assigning preliminary approvals for scientific events Commission for the establishment of retail pharmacies and chambers of appeal (Frenchspeaking chamber and Dutch-speaking chamber) Commission for the recognition of pharmacists-clinical biologists Commission for the supervision of advertising for medicines for human use Evaluation commission for active implantable medical devices Evaluation commission for homeopathic medicines Evaluation commission for medical devices Evaluation commission for medicines for human use Evaluation commission for medicines for veterinary use Evaluation commission for traditional herbal medicines Pharmacopoeia commission
Advisory commission which is consulted e.g. in cases of non-availability of medicines Commission for the approval of institutions assigning preliminary approvals for scientific events Commission for the establishment of retail pharmacies and chambers of appeal (Frenchspeaking chamber and Dutch-speaking chamber) Commission for the recognition of pharmacists-clinical biologists Commission for the supervision of advertising for medicines for human use Evaluation commission for active implantable medical devices Evaluation commission for homeopathic medicines Evaluation commission for medical devices Evaluation commission for medicines for human use Evaluation commission for medicines for veterinary use Evaluation commission for traditional herbal medicines Pharmacopoeia commission

Unit I Unit I is responsible for the tasks of the secretariat of the commission for the establishment of retail pharmacies, of the secretariat of the commission for the recognition of pharmacists-clinical biologists, of the retail pharmacies registry and plays an important role in the problems of products in the “grey area” (these are “borderline” products whose exact status has to be determined: is it a medicine or not?).
Unit I Unit I is responsible for the tasks of the secretariat of the commission for the establishment of retail pharmacies, of the secretariat of the commission for the recognition of pharmacists-clinical biologists, of the retail pharmacies registry and plays an important role in the problems of products in the “grey area” (these are “borderline” products whose exact status has to be determined: is it a medicine or not?).

narcotics and concerning risk limitation and therapeutic advice and of 22 January 1998 governing certain psychotropic substances and concerning risk limitation and therapeutic advice and of 12 April 1974 containing certain provisions relating to substances with hormonal, antihormonal, anabolic, beta-adrenergic, anti-infectious, antiparasitic and anti-inflammatory action Law of 15 July 1985 on the use in animals of substances with hormonal, anti-hormonal, beta-adrenergic or production stimulating action Law of 13 June 1986 on the removal and transplanting of organs, with regard to cells and tissues Law of 28 August 1991 on the practice of veterinary medicine, regarding the provision of medicines to animal carers Law of 5 July 1994 on blood and blood derivatives of human origin Law of 7 May 2004 on experiments on the human person Royal decree of 31 May 1885 approving new instructions for physicians, pharmacists and druggists Royal decree of 22 September 1966 on the conditions and arrangements for the recognition of laboratories for the analysis and checking of medicines Royal decree of 6 June 1960 on the production, preparation and wholesale distribution and delivery of medicines Royal decree no. 78 of 10 November 1967 on the practice of the healthcare professions regarding the dispensing of medicines to the public and Royal decree of 25 September
narcotics and concerning risk limitation and therapeutic advice and of 22 January 1998 governing certain psychotropic substances and concerning risk limitation and therapeutic advice and of 12 April 1974 containing certain provisions relating to substances with hormonal, antihormonal, anabolic, beta-adrenergic, anti-infectious, antiparasitic and anti-inflammatory action Law of 15 July 1985 on the use in animals of substances with hormonal, anti-hormonal, beta-adrenergic or production stimulating action Law of 13 June 1986 on the removal and transplanting of organs, with regard to cells and tissues Law of 28 August 1991 on the practice of veterinary medicine, regarding the provision of medicines to animal carers Law of 5 July 1994 on blood and blood derivatives of human origin Law of 7 May 2004 on experiments on the human person Royal decree of 31 May 1885 approving new instructions for physicians, pharmacists and druggists Royal decree of 22 September 1966 on the conditions and arrangements for the recognition of laboratories for the analysis and checking of medicines Royal decree of 6 June 1960 on the production, preparation and wholesale distribution and delivery of medicines Royal decree no. 78 of 10 November 1967 on the practice of the healthcare professions regarding the dispensing of medicines to the public and Royal decree of 25 September

Unit II Unit II is responsible for: ●● The recognition of industrial pharmacists ●● The granting of authorisations for the manufacture, import, export, wholesale, distribution of medicines ●● Dealing with quality problems (RAS – Rapid
Unit II Unit II is responsible for: ●● The recognition of industrial pharmacists ●● The granting of authorisations for the manufacture, import, export, wholesale, distribution of medicines ●● Dealing with quality problems (RAS – Rapid

Decision analytic model (time horizon 1 year) US Payer (third party payer or patient) Pharmacist advice alone Pharmacist advice+NRT patch Pharmacist advice+NRT gum Pharmacist advice+bupropion Study funded by an American Pharmaceutical Association Foundation Incentive Grant
Decision analytic model (time horizon 1 year) US Payer (third party payer or patient) Pharmacist advice alone Pharmacist advice+NRT patch Pharmacist advice+NRT gum Pharmacist advice+Buproprion Study funded by an American Pharmaceutical Association Foundation Incentive Grant

Pharmacist counselling alone 190 25% 25% Pharmacist counselling+NRT patch 344.36 25% 35% Pharmacist counselling+NRT gum 408.78 25% 20% Pharmacist counselling+bupropion 391.39 25% 20%
Pharmacist counselling alone 190 25% 25% Pharmacist counselling+NRT patch 344.36 25% 35% Pharmacist counselling+NRT gum 408.78 25% 20% Pharmacist counselling+Buproprion 391.39 25% 20%

–– 48 % pharmacists, of which 25 % were hospital pharmacists and 23 % retail pharmacists
–– 48 % pharmacists, of which 25 % were hospital pharmacists and 23 % retail pharmacists

Co-ordination Group for Mutual recognition and Decentralised Procedure, human
Co-ordination Group for Mutual recognition and Decentralised Procedures-human

Het einddoel is om tot een geharmoniseerde toepassing te komen van de inspectienormen binnen de EU en in de landen waarmee een wederzijds erkenningsakkoord (Mutual Recognition Agreement, MRA) afgesloten werd.
L’objectif est de parvenir à une application harmonisée des normes d’inspection au sein de l’UE ainsi que dans les pays avec lesquels un accord de reconnaissance mutuel (Mutual Recognition Agreement, MRA) a été conclu.

2000 US$ Average retail price of NRT gum (12-week course): US$218.78 Average retail price of NRT patch (8-week course): US$154.36 Average retail price of bupropion (8-week course): US$201.39 Pharmacist time (5 hours of intervention, US$35/hr): US$175 Technician support (2 hours, US$5/hr): US$10 Material costs: US$5 0%
2000 US$ Average retail price of NRT gum (12-week course): US$218.78 Average retail price of NRT patch (8-week course): US$154.36 Average retail price of Buproprion (8-week course): US$201.39 Pharmacist time (5 hours of intervention, US$35/hr): US$175 Technician support (2 hours, US$5/hr): US$10 Material costs: US$5 0%